Cargando…
Current status of PET/CT in the diagnosis and follow up of lymphomas
Lymphomas are a heterogeneous group of malignancies that have a distinct biological behavior according to the subtype and degree of differentiation. Adequate staging, which has a direct impact on prognosis, is essential to properly plan therapy. Structural cross-sectional imaging, such as computed t...
Autor principal: | Buchpiguel, Carlos Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Hematologia e Hemoterapia
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520639/ https://www.ncbi.nlm.nih.gov/pubmed/23284262 http://dx.doi.org/10.5581/1516-8484.20110035 |
Ejemplares similares
-
(18)F-FDG PET/CT in the Follow-Up of Mucosal Leishmaniasis
por: Camargo, Raphael A., et al.
Publicado: (2018) -
FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects
por: Al-Ibraheem, Akram, et al.
Publicado: (2023) -
Is the (18)F-FDG PET/CT the definite resource to detect the recurrence on high-risk thyroid cancer patients?
por: Buchpiguel, Carlos Alberto
Publicado: (2017) -
Is (18)F-FDG PET/CT a real breakthrough imaging test in
predicting the outcome of percutaneous ablation of metastases?
por: Buchpiguel, Carlos Alberto
Publicado: (2019) -
PET/CT: Current status in India
por: Rangarajan, Venkatesh, et al.
Publicado: (2008)